Publicaciones en colaboración con investigadoras/es de Hospital Clinic Barcelona (32)

2024

  1. C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration

    Frontiers in Immunology, Vol. 15

  2. Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©

    Ophthalmology and Therapy, Vol. 13, Núm. 6, pp. 1669-1682

2023

  1. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  2. Diagnostic and Management Strategies of Tubulointerstitial Nephritis and Uveitis Syndrome (TINU): Current Perspectives

    Clinical Ophthalmology, Vol. 17, pp. 2625-2630

  3. Herpetic Anterior Uveitis Multicentre Longitudinal Study (The UVHER Project). Baseline Characteristics

    Ocular Immunology and Inflammation, Vol. 31, Núm. 7, pp. 1497-1504

  4. Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature

    European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14

  5. Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055

2022

  1. Guía de recomendaciones para el manejo de brolucizumab

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 11, pp. 626-638

2021

  1. Impacto de la infección por el nuevo coronavirus en los pacientes con uveítis asociada a una enfermedad autoinmune: resultado de la encuesta COVID-19-GEAS pacientes

    Archivos de la Sociedad Española de Oftalmologia, Vol. 96, Núm. 7, pp. 347-352

  2. Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group

    Revista Clinica Espanola, Vol. 221, Núm. 4, pp. 221-225

  3. Remote screening of retinal and optic disc diseases using handheld nonmydriatic cameras in programmed routine occupational health checkups onsite at work centers

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 259, Núm. 3, pp. 575-583

2020

  1. Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group

    Ophthalmology

  2. Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema

    Frontiers in Immunology, Vol. 11

  3. Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach

    European Journal of Ophthalmology, Vol. 30, Núm. 5, pp. 1042-1052

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

  2. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, Núm. 11, pp. 2381-2390

  3. Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis

    PLoS ONE, Vol. 14, Núm. 1

2018

  1. Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study

    BMC Ophthalmology

  2. Functionally distinct ERAP1 and ERAP2 are a hallmark of HLA-A29-(Birdshot) Uveitis

    Human molecular genetics, Vol. 27, Núm. 24, pp. 4333-4343

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656